Memorial Sloan Kettering Cancer Center (MSK) has been ranked the world’s leading cancer hospital in Newsweek’s World’s Best Specialized Hospitals 2027 ranking, maintaining its position as the highest-ranked oncology institution globally.
The New York-based cancer center secured the No. 1 position in oncology worldwide, ahead of other leading cancer institutions, including MD Anderson Cancer Center in Houston and Gustave Roussy in France.
The annual ranking, developed by Newsweek in partnership with Statista, evaluates specialized hospitals across multiple medical fields, including oncology. The methodology incorporates international expert recommendations, hospital quality indicators, certifications and accreditations, and patient-reported outcome measures.
A Century of Advancing Cancer Care
Founded in 1884, Memorial Sloan Kettering Cancer Center has become one of the world’s most recognized institutions dedicated exclusively to cancer.
MSK’s model integrates patient care, laboratory research, clinical trials, and education to translate scientific discoveries into new approaches to cancer prevention, diagnosis, and treatment.
The institution brings together more than 20,000 physicians, scientists, nurses, and other healthcare professionals working across its clinical and research programs.
Research and Innovation at the Core of MSK’s Mission
MSK has played a major role in advancing modern oncology, from developing new treatment approaches to expanding precision medicine.
The center conducts thousands of clinical trials and research studies each year, investigating areas including:
- Immunotherapy and cellular therapies
- Precision oncology and genomic medicine
- Targeted therapies
- Cancer vaccines
- Early detection and prevention
- Artificial intelligence and computational oncology
Through programs such as the Center for Molecular Oncology, MSK uses genomic profiling to help match patients with therapies based on the molecular characteristics of their tumors.
Expanding Access to Personalized Cancer Treatment
MSK continues to develop new approaches aimed at making cancer care more personalized and effective.
The institution’s clinical programs span more than 400 cancer types and subtypes, offering specialized expertise across medical oncology, surgery, radiation oncology, pediatric oncology, and supportive care.
Its investigators have contributed to major advances in cancer treatment, including the development and evaluation of therapies that have changed clinical practice worldwide.
Commitment Beyond Treatment
Beyond clinical care and research, MSK emphasizes education and training for the next generation of cancer professionals.
Through its fellowship, residency, and research training programs, MSK supports physicians, scientists, and healthcare professionals who contribute to the future of oncology.
Newsweek’s recognition highlights MSK’s continued international reputation as a center where multidisciplinary cancer care and scientific innovation combine to advance treatment for patients worldwide.
Top 10 Cancer Hospitals in the World: Newsweek 2027 Ranking
According to Newsweek’s World’s Best Specialized Hospitals 2027 oncology ranking, the top 10 cancer hospitals worldwide are:
- Memorial Sloan Kettering Cancer Center — New York, United States
- MD Anderson Cancer Center — Houston, United States
- Gustave Roussy — Villejuif, France
- The Royal Marsden Hospital — London, United Kingdom
- Samsung Medical Center — Seoul, South Korea
- Asan Medical Center — Seoul, South Korea
- Mayo Clinic — Rochester, United States
- The Johns Hopkins Hospital — Baltimore, United States
- Dana-Farber Brigham Cancer Center / Brigham and Women’s Hospital — Boston, United States
- Charité – Universitätsmedizin Berlin — Berlin, Germany
MSK’s continued recognition at the top of the Newsweek oncology ranking reflects its longstanding focus on integrating research, innovation, and multidisciplinary cancer care to improve outcomes for people living with cancer.
Read further on OncoDaily: Gustave Roussy Named Europe’s No. 1 Cancer Center and Third Worldwide in Newsweek 2027 Ranking
